Population-based cohort study identifies better treatment objectives for women with advanced-stage ovarian cancer.
Inotuzumab ozogamicin (InO) is an active antibody-drug conjugate that works by delivering the chemotherapeutic payload calicheamicin to cells expressing CD22. Studies demonstrate that InO elicits high ...
The incidence of head and neck cancer increased among patients in the cannabis-related disorder group compared with patients without cannabis-related disorder (0.285% vs 0.091%, respectively).